CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects

Area of Science:

• Immunology
• Transplantation Science
• Cellular Therapy

Background:

• CD4(+)CD25(+) regulatory T cells (Tregs) are vital for immune homeostasis and preventing autoimmune diseases.
• Evidence suggests Tregs play a role in allograft rejection and current immunotherapies.
• The precise relevance of Tregs in clinical transplantation remains incompletely understood despite rodent model studies.

Purpose of the Study:

• To review the current understanding of Treg involvement in immunity and organ transplantation.
• To summarize advances in utilizing Tregs for immune therapy.
• To identify complexities and opportunities for using antigen-specific Tregs in transplantation.

Main Methods:

• Literature review of experimental and clinical studies on Tregs in transplantation.
• Analysis of Treg development, function, and therapeutic efficacy.
• Synthesis of current knowledge on Treg-based immunotherapies.

Main Results:

• Tregs are established players in immune homeostasis and autoimmunity.
• Treg function in allograft rejection and immunotherapy is increasingly recognized.
• Significant gaps exist in translating Treg knowledge from rodent models to human clinical transplantation.

Conclusions:

• Tregs have a complex role in transplantation immunity.
• Antigen-specific Tregs offer a promising strategy for inducing immune tolerance in transplant recipients.
• Further research is needed to optimize Treg-based therapies for clinical application.